Marpai (MRAI) AI Stock Analysis

• Market Cap: $7.59M
• Dividend Yield: N/A
• Average Volume (3M): 20.43K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.34
• Revenue Growth: -31.65%
• EPS Growth: 70.58%
• Country: US
• Employees: 117
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Plans
• EPS (TTM): N/A
• Shares Outstanding: 25,292,667
• 10 Day Avg. Volume: 21,648
• 30 Day Avg. Volume: 20,435
• PEG Ratio: 0.01
• Price to Book (P/B): -0.34
• Price to Sales (P/S): 0.61
• P/FCF Ratio: -1.47
• Enterprise Value/Market Cap: 0.77
• Enterprise Value/Revenue: 0.32
• Enterprise Value/Gross Profit: 1.24
• Enterprise Value/Ebitda: -0.45
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $0.27 ▼(-63.56% Downside)
• Action: Reiterated Date: 03/27/26
• Date: Action: Reiterated 03/27/26

The score is weighed down primarily by deteriorating revenue, ongoing large losses, negative equity, and continued cash burn. Technicals also indicate a sustained downtrend with weak momentum. Cost-cutting actions and financing/new-business progress noted on the earnings call provide some offset, but liquidity remains a key risk as underscored by the recent CEO loan.

Positive Factors

Operating expense reduction

Sustained opex reductions materially lower cash burn and narrow operating losses, improving runway and funding for strategic initiatives. If maintained, structurally lower operating costs improve the path to break-even by reducing fixed-cost leverage needed per incremental revenue.

Negative Factors

Sharp revenue decline

A persistent, large top-line decline erodes scale economics and the gross-profit base needed to cover fixed costs. Reduced revenue weakens bargaining power, limits reinvestment in sales and product, and makes achieving durable profitability harder despite cost cuts.

Marpai Business Overview & Revenue Model

Company Description

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial servi...

Read more

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial servi...

How the Company Makes Money

Marpai makes money primarily by providing administrative services for employer-sponsored health plans, particularly self-funded plans, where the employer bears the medical-claims risk and hires a TPA to run day-to-day plan operations. Revenue is g...

Read more

Marpai makes money primarily by providing administrative services for employer-sponsored health plans, particularly self-funded plans, where the employer bears the medical-claims risk and hires a TPA to run day-to-day plan operations. Revenue is g...

Marpai Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	18.10M	28.17M	37.16M	24.34M	14.23M
Gross Profit	4.78M	9.11M	12.92M	7.21M	3.94M
EBITDA	-13.09M	-23.73M	-22.12M	-22.55M	-13.65M
Net Income	-16.56M	-22.09M	-28.75M	-26.47M	-15.98M
Balance Sheet
Total Assets	10.90M	12.88M	31.68M	49.95M	44.20M
Cash, Cash Equivalents and Short-Term Investments	133.00K	764.00K	1.15M	13.76M	19.18M
Total Debt	792.00K	1.04M	4.20M	6.08M	1.30T
Total Liabilities	43.47M	40.59M	45.12M	43.82M	14.49M
Stockholders Equity	-32.56M	-27.71M	-13.44M	6.13M	29.71M
Cash Flow
Free Cash Flow	-7.45M	-15.16M	-15.75M	-36.20M	-12.54M
Operating Cash Flow	-7.45M	-15.16M	-15.75M	-35.24M	-10.79M
Investing Cash Flow	500.00K	227.00K	1.03M	32.42M	9.64M
Financing Cash Flow	6.67M	10.67M	5.10M	196.00	25.27M

Marpai Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.73
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MRAI, the sentiment is Negative. The current price of 0.73 is above the 20-day moving average (MA) of 0.46, above the 50-day MA of 0.52, and below the 200-day MA of 1.03, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 34.44 is Neutral, neither overbought nor oversold. The STOCH value of 12.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MRAI.

Marpai Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OSCR	61 Neutral	$3.32B	-8.51	-39.45%	―	37.38%	-912.18%
ALHC	60 Neutral	$3.40B	-88.83	-0.49%	―	47.39%	85.35%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CLOV	50 Neutral	$918.17M	-14.21	-25.73%	―	15.23%	38.79%
MRAI	41 Neutral	$7.59M	―	―	―	-31.65%	70.58%

Marpai Corporate Events